Simian immunodeficiency virus (SIV)-specific CD8+ cytotoxic T lymphocyte responses of naive and vaccinated cynomolgus macaques infected with SIVmac32H(J5): Quantitative analysis by in vitro antigenic stimulation

Vaccine

Volumn 15, Issue 11, 1997, Pages 1269-1275

  Geretti, Anna Maria ^a,b   Hulskotte, Ellen G J ^a   Dings, Marlinda E M ^a   Van Baalen, Carel A ^a   Van Amerongen, Geert ^c   Osterhaus, Albert D M E ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b Div of Pathol/Communic Dis   (United Kingdom)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Animal models; Protective immunity; Recombinant antigens

Indexed keywords

CD8 ANTIGEN; SIMIAN IMMUNODEFICIENCY VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; LYMPHOCYTE ACTIVATION; MACACA; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINATION; VIRUS INFECTION;

ANIMALS; ANTIBODY SPECIFICITY; ANTIGENS, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY TESTS, IMMUNOLOGIC; GENE PRODUCTS, GAG; INDICATOR DILUTION TECHNIQUES; KINETICS; MACACA FASCICULARIS; SAIDS VACCINES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; VACCINATION;

EID: 0030823803     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00029-7     Document Type: Article

References (26)

1. Zinkernagel, R.M. Are HIV-specific CTL responses salutary or pathogenic? Curr. Opin. Immunol. 1995, 7, 462-470.
2. Desrosiers, R. The simian immunodeficiency viruses. A. Rev. Immunol. 1990, 8, 557-578.
3. Letvin, N.L., Reimann, K.A., Yasutomi, Y., Ringler, D.J. and Yamamoto, H. The SIVmac specific cytotoxic T lymphocyte response in the acutely infected rhesus monkey. Curr. Top. Microbiol. Immunol. 1994, 188, 175-184.
4. Hulskotte, E.G.J., Geretti, A.M. and Siebelink, K.H.J. et al. Vaccine-induced virus-neutralizing antibodies and cytotoxic T cells do not protect macaques from experimental infection with simian immunodeficiency virus SIVmac 32H (J5). J. Virol. 1995, 69, 6289-6296.
5. Newman, M.J., Munroe, K.J. and Anderson, C.A. et al. Induction of antigen-specific killer T lymphocyte responses using subunit SIVmac251 gag and env vaccines containing QS-21 saponin adjuvant. AIDS Res. Hum. Retroviruses 1994, 10, 853-861.
6. Yasutomi, Y., Koenig, S. and Woods, R.M. et al. A vaccine-elicited, single viral epitope-specific cytotoxic T lymphocyte response does not protect against cell-free simian immunodeficiency virus challenge. J. Virol. 1995, 69, 2279-2284.
7. + nef-specific cytotoxic T cells in vaccinated macaques. Nature Med. 1995, 1, 1167-1173.
8. Berzofsky, J.A. Epitope selection and design of synthetic vaccines: molecular approaches to enhancing immunogenicity and crossreactivity of engineered vaccines. Ann. N.Y. Acad. Sci. 1993, 690, 256-264.
9. Venet, A., Bourgault, I., Aubertin, A.M., Kieny, M.P. and Levy, J.P. Cytotoxic T-lymphocyte response against multiple simian immunodeficiency virus (SIV) proteins in SIV-infected macaques. J. Immunol. 1992, 148, 2899-2908.
10. + T cells in macaques protected from SIV challenge by prior subunit vaccination. J. Virol. 1996, 70, 4941-4947.
11. Cease, K.B. and Berzofsky, J.A. Toward a vaccine for AIDS: the emergence of immunobiology-based vaccine development. A. Rev. Immunol. 1994, 12, 923-989.
12. Van Baalen, C.A., Klein, M.R. and Geretti, A.M. et al. Selective in vitro expansion of HLA class I-restricted HIV-1 Gag-specific T cells: cytotoxic T-lymphocyte epitopes and precursor frequencies. AIDS 1993, 7, 781-786.
13. Geretti, A.M., Dings, M.E.M. and Van Els, C.A.C.M. et al. HIV-1 and EBV specific cytotoxic T lymphocyte precursors exhibit different kinetics in HIV-1 infected persons. J. Infect. Dis. 1996, 174, 34-45.
14. Rud, E.W., Cranage, M. and Yon, J. et al. Molecular and biological characterization of simian immunodeficiency virus macaque strain 32H proviral clones containing nef size variants. J. Gen. Virol. 1994, 75, 529-543.
15. Chen, Z.W., Shen, L., Miller, M.D., Ghim, S.H., Hughes, A.L. and Letvin, N.L. Cytotoxic T lymphocytes do not appear to select for mutations in an immunodominant epitope of simian immunodeficiency virus gag. J. Immunol. 1992, 149, 4060-4066.
16. + T lymphocytes following anti-Fab detachment from immunomagnetic beads. J. Immunol. Methods 1993, 161, 129-133.
17. Gotch, F., Hovell, R., Delchambre, M., Silvera, P. and McMichael, A. CTL responses to simian immunodeficiency virus by cynomolgus macaques immunised with recombinant vaccinia virus. AIDS 1991, 5, 317-320.
18. Koup, H.A., Pikora, C.A. and Luzuriaga, K. et al. Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities. J. Exp. Med. 1991, 174, 1593-1600.
19. Strijbosch, L.W.G., Does, R.J.M.M. and Buurman, W.A. Computer aided design and evaluation of limiting and serial dilution experiments. Int. J. Biomed. Comput. 1988, 23, 279-290.
20. + (helper) T cells or erogenous cytokines. J. Immunol. 1988, 140, 1994-1998.
21. Johnson, R.P. and Walker, B.D. Cytotoxic T lymphocytes in human immunodeficiency virus infection: responses to structural proteins. Curr. Top. Microbiol. Immunol. 1994, 189, 35-63.
22. Koup, R.A., Safrit, J.T. and Cao, Y. et al. Temporal association of cellular immune response with the initial control of viremia in primary HIV-1 syndrome. J. Virol. 1994, 68, 4650-4655.
23. Nowak, M.A., May, R.M. and Phillips, R.E. et al. Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature 1995, 375, 606-611.
24. + lymphocyte activity. J. Infect. Dis. 1995, 172, 329-339.
25. Lubaki, M.N., Egan, M.A., Siliciano, R.F., Weinhold, K.J. and Bollinger, R.C. A novel method for detection and ex vivo expansion of HIV type 1-specific cytolytic T lymphocytes. AIDS Res. Hum. Retroviruses 1994, 10, 1427-1431.
26. Kent, S.J., Stallard, V. and Corey, L. et al. Analysis of cytotoxic T lymphocyte responses to SIV proteins in SIV-infected macaques using antigen-specific stimulation with recombinant vaccinia and Fowl poxviruses. AIDS Res. Hum. Retroviruses 1994, 10, 551-560.